Slingshot members are tracking this event:
GlycoMimetics (GLYC) and Pfizer (PFE) Initiate Phase 1 Trial Evaluating Subcutaneous Administration of Rivipansel in Vaso-Occlusive Crisis in Sickle Cell Disease
Slingshot Insights Explained
Oct 29, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Sickle Cell Disease, Rivipansel, Vaso-occlusive Crisis (voc), Phase 1/2